Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis - Wikidata - wikimedia - TriplyDB

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis

http://www.wikidata.org/entity/Q33909330

about

Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes Diagnosis and management of patients with malignant peritoneal mesothelioma Malignant peritoneal mesothelioma: a review A Histomorphologic Grading System That Predicts Overall Survival in Diffuse Malignant Peritoneal Mesothelioma With Epithelioid Subtype Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis.Advances in malignant peritoneal mesothelioma.Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment Protocols.The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009.Regional delivery of oncolytic vaccinia virus: it's time for clinical trials.Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies.Diagnostic Dilemma: Primary Peritoneal Mesothelioma With Para-Occupational Asbestos Exposure.Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review.Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.Predictive factors analysis for malignant peritoneal mesothelioma.Radiological predictors of complete cytoreduction in 59 patients with peritoneal mesothelioma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a UK referral centre.Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives

P2860

Q26744031-03DFBBB7-44FB-4A5D-AC21-F158CE7BCE34 Q26768299-0512932F-A7FB-4F99-A6C3-F34D40212120 Q26768364-DCB5C145-3376-4205-8E5E-DA6FFD1CC8CE Q33871582-170EF871-D107-437B-ADB2-EFD1BC73637D Q37268597-7FB32267-D58B-4C71-9F5D-3A6DFE8437D4 Q38240009-602FDE4E-C8FA-4E2B-B370-B381669FDE7E Q38261500-84143B06-89F5-42FF-BAD8-AE2D3C96A4EF Q38761720-7477251C-1446-40EA-B0E6-47135A96D2E9 Q38950690-A327AA0A-4C81-41DA-B029-37D650711D41 Q40072339-A3665120-622C-4BD1-A3D6-9F0B40F09CF8 Q42560832-9B0EB361-EC1D-4920-9748-487B3BD0E105 Q46560174-18B2FF14-9D45-401D-8B1B-E5083BE4DF1A Q47114906-A4AF3351-FEA7-4828-B560-A851A05CF0D7 Q47133971-9338A6C7-67FB-49A7-8653-0374959FCF43 Q50091853-16229025-EF84-4554-92E3-30E922895334 Q51045173-6E564999-BE6C-4FF2-9615-D4FBC8BABC1D Q51803157-715CBF04-7817-46DB-9651-DDFA50500CD2 Q58541846-76203549-DE52-4D76-8A47-C45F27F0421E

P2860

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis

http://www.wikidata.org/entity/Q33909330

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis

@ast

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis

@en

type

label

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis

@ast

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis

@en

prefLabel

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis

@ast

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis

@en

P1433

Q33909330-2CBA2113-73B0-4B92-8E9C-A985944C24AB

P1476

Q33909330-9AB71895-38A5-43DE-807F-29348C06ED93

P2093

Q33909330-2FBD37E8-055B-4555-A599-AA4D58554440

Q33909330-30D024A0-BE0A-4856-89EA-D4D4A41E1412

Q33909330-3172B343-B841-44DC-91D9-578E78B9D125

Q33909330-4C84B27E-9329-4821-8DFC-1183054B5B30

Q33909330-5112C719-7625-48A4-81FD-6AAE51773991

Q33909330-8CCBF877-04CA-4190-8E10-4A69E00ADA98

Q33909330-A2C07B63-DD36-4751-A9B1-DBBA8737BB5D

Q33909330-B2199106-913A-4AC4-845A-76825ED5B006

Q33909330-B90FA5F9-CDD0-4179-BA90-2371C3BF5852

Q33909330-C2EA88D2-0153-44B0-93E1-42905558E937

P2860

Q33909330-03CAD09A-21B3-467B-AF12-6C8A597634D0

Q33909330-05B20E13-5A54-4B7F-AA07-2B2910E9738D

Q33909330-0A2393B3-C6CA-4165-AC88-6814F00D0068

Q33909330-18651A40-33BC-4AB5-B30C-A4928D374D79

Q33909330-23B785B3-2125-45C2-AF89-E8381BAE11D8

Q33909330-260424F4-DE27-4378-B2B2-B47C25739DDA

Q33909330-30CE0695-B9A1-486F-965A-8A6D54B2AA01

Q33909330-3ADEE10D-F53C-42B3-AD43-EB8FBE524624

Q33909330-4D0E114A-020A-4A8B-9251-759B7903673B

Q33909330-542BA673-1A18-4262-90C9-3F91041038F4

P2888

Q33909330-8A37F7C0-5BF3-4AE1-A2BD-323294154840

P304

Q33909330-466840F2-8B28-4062-9C8D-572694400186

P31

Q33909330-ABA0D571-6F4B-44B2-A928-EC2A4A5D4B34

P356

Q33909330-624BF1E9-3845-4127-8619-73D00D220763

P433

Q33909330-F2AD43B9-2BAB-432A-A10D-0772C1C4F8E5

P478

Q33909330-98C78224-732A-4A39-A109-A16ACBF6C535

P50

Q33909330-48D4D12F-9BB3-4139-9C2F-4D9C00615AF4

P577

Q33909330-262259E1-E384-4EED-8477-F22F650B4D06

P6179

Q33909330-8D6B7B4E-F288-42D9-8599-EB82F35621E6

P698

Q33909330-A73AA577-E4A1-4623-8A02-4E41F6C88338

P932

Q33909330-3BE683CC-DB1D-4B86-AE43-F1AB5E8DB52A

P356

S10434-013-3358-Y

P1433

Annals of Surgical Oncology

P1476

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis

@en

P2093

Amer H Zureikat

http://www.w3.org/2001/XMLSchema#string

Arun Mavanur

http://www.w3.org/2001/XMLSchema#string

David L Bartlett

http://www.w3.org/2001/XMLSchema#string

Deepa Magge

http://www.w3.org/2001/XMLSchema#string

Frances Austin

http://www.w3.org/2001/XMLSchema#string

Haroon A Choudry

http://www.w3.org/2001/XMLSchema#string

Heather Jones

http://www.w3.org/2001/XMLSchema#string

Herbert J Zeh

http://www.w3.org/2001/XMLSchema#string

James Pingpank

http://www.w3.org/2001/XMLSchema#string

Lekshmi Ramalingam

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003.

Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.

Second generation sequencing of the mesothelioma tumor genome.

Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms

A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Malignant peritoneal mesothelioma.

Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.

Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.

P2888

s10434-013-3358-y

P304

1159-1165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-013-3358-Y

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Steven A. Ahrendt

P577

2013-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1016950650

http://www.w3.org/2001/XMLSchema#string

P698

24322529

http://www.w3.org/2001/XMLSchema#string

P932

4100549

http://www.w3.org/2001/XMLSchema#string